Media coverage
1
Media coverage
Title SOF/VEL/VOX Results in High SVR12 Rates When Administered for 12 Weeks in DAA-Experienced Patients or for 8 Weeks in DAA-Naïve Patients: an Integrated Analysis of the POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4 Studies Media name/outlet National AIDS Treatment Advocacy Project Country United States Date 4/25/17 Persons Eric J Lawitz